DZ Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.03B | Buy |
12,811,902
+5,079,892
| +66% | +$419M | 0.91% | 28 |
|
|
2025
Q4 | $659M | Sell |
7,732,010
-1,508,187
| -16% | -$124M | 0.57% | 43 |
|
|
2025
Q3 | $719M | Buy |
9,240,197
+110,840
| +1% | +$8.66M | 0.63% | 44 |
|
|
2025
Q2 | $714M | Buy |
9,129,357
+4,805,819
| +111% | +$358M | 0.71% | 39 |
|
|
2025
Q1 | $313M | Buy |
4,323,538
+4,247,627
| +5,596% | +$304M | 0.35% | 79 |
|
|
2024
Q4 | $5.62M | Buy |
75,911
+31,264
| +70% | +$2.19M | 0.01% | 413 |
|
|
2024
Q3 | $2.95M | Sell |
44,647
-114,937
| -72% | -$8.35M | ﹤0.01% | 535 |
|
|
2024
Q2 | $14.7M | Sell |
159,584
-23,015
| -13% | -$2.04M | 0.02% | 293 |
|
|
2024
Q1 | $17.4M | Sell |
182,599
-306,021
| -63% | -$25.7M | 0.02% | 277 |
|
|
2023
Q4 | $37.3M | Sell |
488,620
-969,997
| -67% | -$67.5M | 0.05% | 198 |
|
|
2023
Q3 | $101M | Sell |
1,458,617
-7,040,366
| -83% | -$566M | 0.14% | 102 |
|
|
2023
Q2 | $802M | Buy |
8,498,983
+769,087
| +10% | +$66.8M | 1.21% | 18 |
|
|
2023
Q1 | $639M | Buy |
7,729,896
+5,404,439
| +232% | +$425M | 1.05% | 29 |
|
|
2022
Q4 | $174M | Buy |
2,325,457
+2,017,801
| +656% | +$156M | 0.3% | 67 |
|
|
2022
Q3 | $25.4M | Sell |
307,656
-17,466
| -5% | -$1.68M | 0.05% | 198 |
|
|
2022
Q2 | $30.9M | Sell |
325,122
-95,274
| -23% | -$9.86M | 0.06% | 200 |
|
|
2022
Q1 | $49.5M | Sell |
420,396
-45,033
| -10% | -$5.05M | 0.07% | 156 |
|
|
2021
Q4 | $60.4M | Sell |
465,429
-215,503
| -32% | -$25.1M | 0.09% | 149 |
|
|
2021
Q3 | $77.1M | Sell |
680,932
-178,024
| -21% | -$20.3M | 0.12% | 113 |
|
|
2021
Q2 | $89M | Buy |
858,956
+87,173
| +11% | +$8.22M | 0.14% | 107 |
|
|
2021
Q1 | $64.6M | Buy |
771,783
+317,502
| +70% | +$26.8M | 0.12% | 129 |
|
|
2020
Q4 | $41.3M | Buy |
454,281
+176,301
| +63% | +$14.6M | 0.09% | 151 |
|
|
2020
Q3 | $22.2M | Buy |
277,980
+130,218
| +88% | +$10.2M | 0.05% | 195 |
|
|
2020
Q2 | $10.2M | Buy |
147,762
+68,331
| +86% | +$4.86M | 0.03% | 265 |
|
|
2020
Q1 | $4.99M | Hold |
79,431
| – | – | 0.02% | 319 |
|
|
2019
Q4 | $6.15M | Sell |
79,431
-36,255
| -31% | -$2.83M | 0.02% | 350 |
|
|
2019
Q3 | $8.48M | Sell |
115,686
-84,534
| -42% | -$5.94M | 0.03% | 298 |
|
|
2019
Q2 | $12.3M | Buy |
200,220
+13,347
| +7% | +$807K | 0.04% | 244 |
|
|
2019
Q1 | $11.9M | Sell |
186,873
-19,512
| -9% | -$1.11M | 0.04% | 241 |
|
|
2018
Q4 | $10.3M | Sell |
206,385
-1,000,314
| -83% | -$50.6M | 0.04% | 242 |
|
|
2018
Q3 | $70M | Sell |
1,206,699
-439,311
| -27% | -$21.5M | 0.25% | 106 |
|
|
2018
Q2 | $79.9M | Buy |
1,646,010
+64,884
| +4% | +$3.03M | 0.3% | 89 |
|
|
2018
Q1 | $73.5M | Buy |
1,581,126
+61,347
| +4% | +$2.66M | 0.28% | 95 |
|
|
2017
Q4 | $57.1M | Sell |
1,519,779
-390,351
| -20% | -$14.3M | 0.22% | 113 |
|
|
2017
Q3 | $69.6M | Buy |
1,910,130
+53,520
| +3% | +$2.04M | 0.29% | 97 |
|
|
2017
Q2 | $73.2M | Sell |
1,856,610
-2,652
| -0.1% | -$96.8K | 0.34% | 84 |
|
|
2017
Q1 | $58.3M | Sell |
1,859,262
-690
| -0% | -$21.6K | 0.27% | 104 |
|
|
2016
Q4 | $58.1M | Buy |
+1,859,952
| New | +$60.3M | 0.28% | 106 |
|
Other funds holding EW
VCM
VPM
DZ Bank's EW Position: Q1 2026 in Review
DZ Bank increased its Edwards Lifesciences (EW) stake by 66% in Q1 2026, buying an estimated $419M and bringing the position to 12,811,902 shares worth $1.03B. The position accounts for 0.91% of the portfolio, ranked #28.
DZ Bank first reported a position in EW in Q4 2016 and has held it in 38 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- DZ Bank held 12,811,902 shares of Edwards Lifesciences worth $1.03B as of Q1 2026.
- DZ Bank bought 5,079,892 Edwards Lifesciences shares in Q1 2026, an estimated $419M.
- Edwards Lifesciences made up 0.91% of DZ Bank's portfolio in Q1 2026, its #28 holding.
- DZ Bank first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 38 quarters since.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.